This study investigates pancreatic ductal adenocarcinoma. The purpose of this study is to validate a noninvasive method using exosome-based miRNA signatures for early detection.
The study evaluates the effectiveness of this method in identifying the condition at its earliest stages by analyzing specific genetic materials in exosomes.
- Who can participate: Adults with pancreatic ductal adenocarcinoma or those without the disease based on imaging or endoscopy may participate. Written informed consent is required.
- Study details: Participants will provide samples for analysis of circulating vesicles, known as exosomes, to detect specific genetic materials called miRNAs.
How understandable was the trial content above?
Hard to understand
Easy to understand